Please use this identifier to cite or link to this item: https://doi.org/10.32598/bcn.11.covid19.1
DC FieldValue
dc.titleCOVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response an international society of addiction medicine practice and policy interest group position paper
dc.contributor.authorFarhoudian, A.
dc.contributor.authorBaldacchino, A.
dc.contributor.authorClark, N.
dc.contributor.authorGerra, G.
dc.contributor.authorEkhtiari, H.
dc.contributor.authorDom, G.
dc.contributor.authorMokri, A.
dc.contributor.authorSadeghi, M.
dc.contributor.authorNematollahi, P.
dc.contributor.authorDemasi, M.
dc.contributor.authorSchutz, C.G.
dc.contributor.authorHashemian, S.M.
dc.contributor.authorTabarsi, P.
dc.contributor.authorGalea-Singer, S.
dc.contributor.authorCarra, G.
dc.contributor.authorClausen, T.
dc.contributor.authorKouimtsidis, C.
dc.contributor.authorTolomeo, S.
dc.contributor.authorRadfar, S.R.
dc.contributor.authorRazaghi, E.M.
dc.date.accessioned2021-08-19T04:30:46Z
dc.date.available2021-08-19T04:30:46Z
dc.date.issued2020
dc.identifier.citationFarhoudian, A., Baldacchino, A., Clark, N., Gerra, G., Ekhtiari, H., Dom, G., Mokri, A., Sadeghi, M., Nematollahi, P., Demasi, M., Schutz, C.G., Hashemian, S.M., Tabarsi, P., Galea-Singer, S., Carra, G., Clausen, T., Kouimtsidis, C., Tolomeo, S., Radfar, S.R., Razaghi, E.M. (2020). COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response an international society of addiction medicine practice and policy interest group position paper. Basic and Clinical Neuroscience 11 (2) : 133-150. ScholarBank@NUS Repository. https://doi.org/10.32598/bcn.11.covid19.1
dc.identifier.issn2008-126X
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/197938
dc.description.abstractCoronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD). © 2020 Iran University of Medical Sciences. All rights reserved.
dc.publisherIran University of Medical Sciences
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScopus OA2020
dc.subjectAddiction medicine
dc.subjectCoronavirus
dc.subjectCoronavirus Disease 2019 (COVID-19)
dc.subjectHarm reduction
dc.subjectMethadone
dc.subjectOpioid substitution therapy
dc.subjectPandemic
dc.subjectPolicy
dc.subjectPublic health
dc.subjectSubstance use disorder
dc.typeReview
dc.contributor.departmentDEAN'S OFFICE (ARTS & SOCIAL SC.)
dc.description.doi10.32598/bcn.11.covid19.1
dc.description.sourcetitleBasic and Clinical Neuroscience
dc.description.volume11
dc.description.issue2
dc.description.page133-150
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_32598_bcn_11_covid19_1.pdf1.12 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons